Symbol
| NRAS
| contributors: mct - updated : 06-05-2016
|
HGNC name
| neuroblastoma RAS viral (v-ras) oncogene homolog
|
HGNC id
| 7989
|
corresponding disease(s)
|
NS6
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
| somatic mutation
|  
|  
|  
|
in multiple myeloma, in primary plasma cell leukemia at an early stage, and in thyroid cancer with poor prognosis | tumoral
| germinal mutation
|  
|  
| gain of function
|
in autoimmune lymphoproliferative syndrome | tumoral
| somatic mutation
|  
|  
|  
|
in high hyperdiploid childhood acute lymphoblastic leukemia | tumoral
| somatic mutation
|  
|  
|  
|
in hepatocellular carcinoma | tumoral
| somatic mutation
|  
|  
|  
|
in primary melanocytic tumours of the CNS, GNA11 and NRAS mutations represent a mechanism of MAPK pathway activation alternative to the common GNAQ mutations( : | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
| | | |
| effect of Nras loss on tumor development in Rb1 heterozygous mice, the loss of the protooncogene Nras in certain cellular contexts can promote malignant tumor progression (Takahashi 2006) |